时间标签：数据日期 2026-11-05 · 生成时间 2026-11-05 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/11/02 – 2026/11/06 ｜ 情报发生日期 2026-11-05
研究问题
These studies provide a rationale for testing whether nicotine responses differ between wild-type and α7-nAChR knockout animals.Nicotine may also act through mechanisms that are not restricted to classical nAChR signaling.；These findings motivate consideration of both receptor-associated and broader metabolic responses; they do not establish that the same mechanisms operate in the present model.We hypothesized that nicotine co-treatment would attenuate selected D-galactose-associated behavioral, inflammatory, and glial alterations, and that some treatment responses would differ according to α7-nAChR genotype.；The key mechanistic question was whether the change produced by nicotine differed directly between genotypes, rather than whether a comparison was significant in wild-type rats but not in knockout rats.
方法
We therefore use the model as a controlled aging-like challenge, not as evidence of established Alzheimer-type pathology.Nicotinic acetylcholine receptors (nAChRs) influence neuronal excitability, intracellular calcium signaling, and neuroimmune communication.；(2018) reported improved memory and reduced mitochondrial oxidative damage and apoptosis in D-galactose-treated mice given nicotine.；(2023) subsequently showed that the α7-nAChR agonist PNU282987 attenuated cognitive, oxidative, inflammatory, and senescence-associated abnormalities in D-galactose-treated rats and BV2 cells, with evidence implicating Nrf2/HO-1 signaling.
核心结论
These findings motivate consideration of both receptor-associated and broader metabolic responses; they do not establish that the same mechanisms operate in the present model.We hypothesized that nicotine co-treatment would attenuate selected D-galactose-associated behavioral, inflammatory, and glial alterations, and that some treatment responses would differ according to α7-nAChR genotype.；A transcript assay outside the deleted region could detect retained RNA without demonstrating an intact functional receptor; residual Chrna7 qPCR signal is therefore not interpreted as evidence of an intact receptor.；These results support endpoint-specific genotype-associated responses for IBA1 immunoreactivity and serum GSH, but do not establish a generalized α7-dependent mechanism.
局限
We did not test this causal sequence, and the transcript results are not evidence that nicotine directly inhibits either secretase.The apparent discrepancy between Bace1 expression and Aβ requires particular caution.；The RNA-seq dataset contains no knockout samples and cannot establish an α7-dependent transcriptional mechanism.4.1Study limitationsThe D-galactose challenge models selected aging-associated processes, not the full course of natural aging or established Alzheimer’s disease.；Small group sizes, variance sensitivity in some comparisons, sex-related heterogeneity in hippocampal IL-6, and within-endpoint rather than study-wide multiplicity correction warrant an exploratory interpretation.
对本项目的价值
中高价值：属「衰老细胞清除 / SASP 轴」方向；细胞衰老 / senolytics / SASP栏目可用作本项目文献库与综述素材。 ｜ 价值分 3.3/5（★★★☆☆）
全文来源
PubMed PMC JATS（正文 61,376 字符，题名指纹 0.92，已过 PubMed PMCID 官方关联 + 题名指纹 + 正文长度归属校验）
原文题录
- 中文题名：尼古丁经 α7-nAChR 相关机制减轻 D-半乳糖诱导的海马衰老样改变
- 英文标题：Nicotine attenuates D-galactose- induced hippocampal aging-like alterations with α7-nAChR- associated mechanisms.
- 期刊与标识：Frontiers in aging neuroscience · PMID 42973616 · DOI 10.3389/fnagi.2026.1947643 · PMC PMC13724548